Showing all 5 results
CJC1295 2MG
CJC-1295, a modified version of GRF 1-29 NO DAC, stands out as a peptide hormone comprising 29 amino acids. Since the early 2000s, this compound has captivated researchers' interest, particularly for its lipolytic properties aimed at visceral fat elimination. A notable attribute of CJC-1295 is its ability to bind with serum albumin, thereby extending its half-life and therapeutic potential.
CJC1295/DAC 2 MG
FRAG 176-191 2MG
Frag 176-191 stands as a groundbreaking advancement in the realm of fat metabolism. Derived from a modified amino acid sequence of growth hormone, Frag 176-191 has garnered significant attention for its lipolytic activity, as evidenced by numerous published studies. This compound operates directly on adipose fat tissues, fostering increased lipolysis and decreased lipogenesis.
IPAMORELIN 2MG
Ipamorelin, also known as NNC 26-0161, emerges as a potent pentapeptide and selective secretagogue of growth hormones, acting as a Ghrelin receptor agonist. With its short chain containing five amino acids and a long half-life, Ipamorelin has showcased significant growth hormone releasing capabilities in both in vivo and in vitro studies. Mimicking the action of GHRP-6, Ipamorelin stimulates growth hormone release from pituitary cells by targeting GHRP-like receptors, without impacting cortisol or ACTH levels.
TB-500 2MG
TB-500, a synthetic form of Thymosin Beta 4 found naturally in animal cells, belongs to a family of 16 related molecules. This peptide plays a crucial role in enhancing the functions of differentiated endothelial cells and regulating actin, a key cellular skeleton protein vital for cellular and genetic architecture. Renowned for its anti-inflammatory and wound healing properties, TB-500 is extensively studied for its potential in skin and muscle building.